S2Medical AB (publ) (S2M.ST)

SEK 0.01

(3.45%)

Operating Income Summary of S2Medical AB (publ)

S2Medical AB (publ)'s latest annual operating income in 2023 was -15.26 Million SEK , up 44.87% from previous year.
S2Medical AB (publ)'s latest quarterly operating income in 2024 Q2 was 6.95 Million SEK , up 812.2% from previous quarter.
S2Medical AB (publ) reported an annual operating income of -27.68 Million SEK in 2022, down -39.59% from previous year.
S2Medical AB (publ) reported an annual operating income of -19.83 Million SEK in 2021, down -32.81% from previous year.
S2Medical AB (publ) reported a quarterly operating income of 6.95 Million SEK for 2024 Q2, up 812.2% from previous quarter.
S2Medical AB (publ) reported a quarterly operating income of -4.57 Million SEK for 2023 Q1, up 34.5% from previous quarter.

Annual Operating Income Chart of S2Medical AB (publ) (2023 - 2015)

Historical Annual Operating Income of S2Medical AB (publ) (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-15.26 Million SEK	44.87%
2022	-27.68 Million SEK	-39.59%
2021	-19.83 Million SEK	-32.81%
2020	-14.93 Million SEK	18.54%
2019	-18.33 Million SEK	-72.86%
2018	-10.6 Million SEK	-103.03%
2017	-5.22 Million SEK	-398.47%
2016	-1.04 Million SEK	-1580.85%
2015	70.77 Thousand SEK	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	762 Thousand SEK	127.24%
2024 Q2	6.95 Million SEK	812.2%
2023 Q1	-4.57 Million SEK	34.5%
2023 FY	-15.83 Million SEK	42.8%
2023 Q3	-3.52 Million SEK	31.09%
2023 Q4	-2.79 Million SEK	20.74%
2023 Q2	-5.12 Million SEK	-11.86%
2022 Q2	-6.19 Million SEK	16.87%
2022 Q1	-7.45 Million SEK	-16.59%
2022 FY	-27.68 Million SEK	-39.59%
2022 Q4	-6.98 Million SEK	0.76%
2022 Q3	-7.04 Million SEK	-13.62%
2021 FY	-19.83 Million SEK	-32.81%
2021 Q1	-4.47 Million SEK	20.26%
2021 Q3	-4.88 Million SEK	-19.77%
2021 Q4	-6.39 Million SEK	-30.85%
2021 Q2	-4.08 Million SEK	8.72%
2020 FY	-14.93 Million SEK	18.54%
2020 Q3	-4.78 Million SEK	-14603.03%
2020 Q4	-5.6 Million SEK	-17.15%
2020 Q2	33 Thousand SEK	100.72%
2020 Q1	-4.57 Million SEK	23.28%
2019 Q2	-5.42 Million SEK	-44.34%
2019 Q1	-3.75 Million SEK	-290.74%
2019 FY	-18.33 Million SEK	-72.86%
2019 Q4	-5.96 Million SEK	-87.03%
2019 Q3	-3.18 Million SEK	41.19%
2018 Q2	-2.22 Million SEK	4.52%
2018 FY	-10.6 Million SEK	-103.03%
2018 Q4	-961.49 Thousand SEK	80.42%
2018 Q3	-4.91 Million SEK	-121.22%
2018 Q1	-2.32 Million SEK	-66.91%
2017 Q2	-1.21 Million SEK	0.0%
2017 Q3	-1.39 Million SEK	-14.27%
2017 FY	-5.22 Million SEK	-398.47%
2017 Q1	-1.21 Million SEK	0.0%
2017 Q4	-1.39 Million SEK	0.0%
2016 FY	-1.04 Million SEK	-1580.85%
2015 FY	70.77 Thousand SEK	0.0%

Peer Operating Income Comparison of S2Medical AB (publ)

Name	Operating Income	Operating Income Difference
AddLife AB (publ)	585 Million SEK	102.609%
Biotage AB (publ)	376 Million SEK	104.06%
Bonesupport Holding AB (publ)	13.93 Million SEK	209.575%
Doxa AB (publ)	269.4 Million SEK	105.666%
Elekta AB (publ)	2.03 Billion SEK	100.749%
iZafe Group AB (publ)	-35.63 Million SEK	57.166%
Ortivus AB (publ)	-17.61 Million SEK	13.333%
Ortivus AB (publ)	-17.61 Million SEK	13.333%
Q-linea AB (publ)	-230.58 Million SEK	93.38%
Synsam AB (publ)	696 Million SEK	102.193%